# Enveda raises USD 311 million Series E

On 2026/9/23, Presspool reported that US AI drug discovery company Enveda had raised USD 311 million in Series E funding led by Catalio Capital Management.



Canonical: https://uniquebase.ai/news/f95641aa-1529-4007-a257-5ead3f3aa3ba
Stable identifier: f95641aa-1529-4007-a257-5ead3f3aa3ba
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-16T00:25:50.049Z

## Connected profiles

- [Catalio Capital Management](/institutions/catalio-capital-management)
- [Enveda](/companies/enveda)

## Sources

- https://presspool.ai/ai-startup-funding/week-of-2026-09-21